CD274 and pachyonychia congenita: This study also addressed heterogeneity in the frequency of immune related biomarkers such as PD-L1/L2, CTLA-4, and B7-H3, which could potentially account for the poor outcomes with ICI in metastatic unselected PC patients (64).